Clover Health Applauds White House and CMS’ Push to “Tear Down Digital Walls,” Accelerating and Simplifying Access to Health Data for Patients and Their Clinicians
Clover Health (NASDAQ:CLOV) has expressed strong support for the White House and CMS' initiative to improve healthcare data accessibility and interoperability. The company's AI platform, Counterpart Assistant, already integrates with most of the networks involved in CMS' Health Tech Ecosystem initiative.
The platform has demonstrated significant clinical outcomes, including 36 months earlier diagnosis and treatment of diabetes, 18% lower hospitalization rates for Congestive Heart Failure, and improved medication adherence. These results contributed to Clover Health PPO plans achieving a 4 Star rating for 2025, with an exceptional 4.94 out of 5 Stars on HEDIS measures.
The company's technology focuses on supporting independent clinicians in rural and underserved areas by providing unified access to patient data from various healthcare sources, enabling better care coordination and improved health outcomes.
Clover Health (NASDAQ:CLOV) ha espresso un forte sostegno all'iniziativa della Casa Bianca e del CMS per migliorare l'accessibilità e l'interoperabilità dei dati sanitari. La piattaforma di intelligenza artificiale dell'azienda, Counterpart Assistant, è già integrata con la maggior parte delle reti coinvolte nell'iniziativa Health Tech Ecosystem del CMS.
La piattaforma ha dimostrato risultati clinici significativi, tra cui una diagnosi e trattamento del diabete anticipati di 36 mesi, un tasso di ospedalizzazione inferiore del 18% per l'insufficienza cardiaca congestizia e un miglioramento nell'aderenza ai farmaci. Questi risultati hanno contribuito ai piani PPO di Clover Health a ottenere una valutazione di 4 stelle per il 2025, con un eccezionale 4,94 su 5 stelle nelle misure HEDIS.
La tecnologia dell'azienda si concentra nel supportare i medici indipendenti nelle aree rurali e svantaggiate, offrendo un accesso unificato ai dati dei pazienti provenienti da diverse fonti sanitarie, permettendo una migliore coordinazione delle cure e risultati sanitari migliorati.
Clover Health (NASDAQ:CLOV) ha manifestado un fuerte apoyo a la iniciativa de la Casa Blanca y CMS para mejorar la accesibilidad e interoperabilidad de los datos de salud. La plataforma de inteligencia artificial de la compañía, Counterpart Assistant, ya está integrada con la mayoría de las redes involucradas en la iniciativa Health Tech Ecosystem de CMS.
La plataforma ha demostrado resultados clínicos significativos, incluyendo un diagnóstico y tratamiento de diabetes 36 meses antes, una reducción del 18% en las tasas de hospitalización por insuficiencia cardíaca congestiva y una mejora en la adherencia a la medicación. Estos resultados contribuyeron a que los planes PPO de Clover Health lograran una calificación de 4 estrellas para 2025, con una excepcional puntuación de 4.94 de 5 estrellas en las medidas HEDIS.
La tecnología de la compañía se enfoca en apoyar a los clínicos independientes en áreas rurales y desatendidas, proporcionando acceso unificado a los datos de pacientes provenientes de diversas fuentes de atención médica, lo que permite una mejor coordinación de la atención y mejores resultados de salud.
Clover Health (NASDAQ:CLOV)는 백악관과 CMS의 의료 데이터 접근성 및 상호운용성 향상 이니셔티브를 강력히 지지한다고 밝혔습니다. 회사의 AI 플랫폼인 Counterpart Assistant는 이미 CMS의 Health Tech Ecosystem 이니셔티브에 참여하는 대부분의 네트워크와 통합되어 있습니다.
이 플랫폼은 당뇨병 조기 진단 및 치료를 36개월 앞당기고, 울혈성 심부전 입원율을 18% 감소시키며, 약물 복용 순응도를 향상시키는 등 중요한 임상 성과를 보여주었습니다. 이러한 결과는 Clover Health PPO 플랜이 2025년 4성 등급을 획득하고, HEDIS 지표에서 5점 만점에 4.94점이라는 뛰어난 평가를 받는 데 기여했습니다.
회사의 기술은 농촌 및 의료 소외 지역의 독립 의료진을 지원하는 데 중점을 두고 있으며, 다양한 의료 출처의 환자 데이터를 통합 접근할 수 있도록 하여 더 나은 진료 조정과 향상된 건강 결과를 가능하게 합니다.
Clover Health (NASDAQ:CLOV) a exprimé un fort soutien à l'initiative de la Maison Blanche et du CMS visant à améliorer l'accessibilité et l'interopérabilité des données de santé. La plateforme d'IA de l'entreprise, Counterpart Assistant, est déjà intégrée à la plupart des réseaux impliqués dans l'initiative Health Tech Ecosystem du CMS.
La plateforme a démontré des résultats cliniques significatifs, notamment un diagnostic et un traitement du diabète anticipés de 36 mois, un taux d'hospitalisation réduit de 18% pour l'insuffisance cardiaque congestive, et une amélioration de l'observance médicamenteuse. Ces résultats ont contribué aux plans PPO de Clover Health qui ont obtenu une notation 4 étoiles pour 2025, avec une performance exceptionnelle de 4,94 sur 5 étoiles aux mesures HEDIS.
La technologie de l'entreprise vise à soutenir les cliniciens indépendants dans les zones rurales et défavorisées en fournissant un accès unifié aux données des patients provenant de diverses sources de soins de santé, permettant une meilleure coordination des soins et une amélioration des résultats de santé.
Clover Health (NASDAQ:CLOV) hat seine starke Unterstützung für die Initiative des Weißen Hauses und des CMS zur Verbesserung der Zugänglichkeit und Interoperabilität von Gesundheitsdaten zum Ausdruck gebracht. Die KI-Plattform des Unternehmens, Counterpart Assistant, ist bereits mit den meisten Netzwerken integriert, die an der Health Tech Ecosystem-Initiative des CMS beteiligt sind.
Die Plattform hat bedeutende klinische Ergebnisse erzielt, darunter eine 36 Monate frühere Diagnose und Behandlung von Diabetes, 18% geringere Krankenhausaufenthaltsraten bei kongestiver Herzinsuffizienz und eine verbesserte Medikamentenadhärenz. Diese Ergebnisse trugen dazu bei, dass Clover Health PPO-Pläne eine 4-Sterne-Bewertung für 2025 erreichten, mit einer herausragenden 4,94 von 5 Sternen bei HEDIS-Maßnahmen.
Die Technologie des Unternehmens konzentriert sich darauf, unabhängige Kliniker in ländlichen und unterversorgten Gebieten zu unterstützen, indem sie einen einheitlichen Zugriff auf Patientendaten aus verschiedenen Gesundheitsquellen ermöglicht, was eine bessere Koordination der Versorgung und verbesserte Gesundheitsergebnisse fördert.
- Achieved 4 Star rating for 2025 PPO plans with 4.94/5 Stars on HEDIS measures
- Platform enables 36 months earlier diagnosis and treatment of diabetes
- Demonstrated 18% lower hospitalization rates and 25% lower 30-day readmissions for CHF patients
- Successfully integrates with majority of CMS-aligned networks for improved data accessibility
- None.
Insights
Clover's tech already implements the CMS interoperability goals, positioning it favorably as industry adapts to new mandates.
Clover Health's announcement reinforces their strategic positioning as a frontrunner in healthcare data interoperability, directly aligning with new White House and CMS initiatives. Their Counterpart Assistant platform has already integrated with most of the networks pledging support for CMS' Health Tech Ecosystem initiative, giving them a significant first-mover advantage as competitors scramble to comply.
The clinical outcomes data presented is particularly noteworthy. Their platform has demonstrated measurable improvements in chronic disease management, including
This alignment with regulatory direction has already yielded tangible benefits in their Medicare Advantage business, as evidenced by their 4-Star rating for 2025, with an exceptional
The strategic significance extends beyond current operations. By highlighting their success with independent practices in rural and underserved areas, Clover is signaling continued expansion into markets traditionally overlooked by competitors. Their technology platform appears to be serving as both a differentiator and enabler for this strategy, potentially creating sustainable competitive advantages as interoperability mandates expand.
Clover Health’s AI platform, Counterpart Assistant, already connects to a majority of the data networks named in yesterday’s pledge – eliminating the “digital walls,” delivering proven outcomes in chronic disease care, and supporting independent doctors caring for seniors in rural and other underserved areas
WILMINGTON, Del., July 31, 2025 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement company bringing access to great healthcare to everyone on Medicare, strongly supports the White House and Centers for Medicare & Medicaid Services’ (CMS) announcement calling on the healthcare industry to “tear down digital walls” and build a truly patient-centric, interoperable ecosystem. The Administration’s leadership is a strong step toward a truly unified healthcare data ecosystem. Clover Health is proud to advance this goal. For years, Clover Health has worked with most of the networks pledging support for the CMS’ Health Tech Ecosystem initiative, to exchange rich patient data and make it available to doctors wherever and whenever they see patients.
“These initiatives are perfectly aligned with our playbook,” said Conrad Wai, CEO of Counterpart Health, Clover’s technology-enabled value based care subsidiary. “Counterpart Assistant has unified more than a hundred different data sources – including leading Health Information Exchanges, Electronic Health Records, labs, pharmacies, and claims feeds – so doctors don’t have to deal with the typical patchwork of healthcare data. Instead, they see a complete longitudinal record for every patient, right when it matters. We’re excited to collaborate on these efforts and accelerate our progress.”
Tearing down digital walls - Counterpart Assistant’s unified data platform synthesizes clinical data from the majority of CMS-aligned networks named in the pledge, delivering true interoperability today. By making real-time lab, pharmacy, hospital, claims, clinical notes, and other health data easily available to physicians as actionable insights at the point of care, Counterpart Assistant tears down the digital walls that historically left clinicians “flying blind.” The result: earlier diagnosis and treatment, fewer duplicative tests, smoother care transitions, and better health outcomes for our seniors.
Supporting independent clinicians caring for patients in rural and other underserved areas - Much of the care delivered via Counterpart Assistant occurs in small, independent practices. These are precisely the groups that are typically shut out of data-sharing initiatives, leading to even more fragmented care, poor patient experiences, and worse health outcomes.
Better health outcomes across chronic conditions - Using proprietary machine learning models, Counterpart Assistant technology improves care coordination for doctors and is correlated with improved patient health, including:
- Diabetes: earlier diagnosis, leading to earlier treatment (an average of 36 months earlier), reduced reliance on insulin, and lower incidence of hypoglycemia at later stages of type 2 diabetes.1
- Congestive Heart Failure (CHF): lower all-cause hospitalizations (
18% lower) and 30-day readmissions (25% lower).2 - Chronic Kidney Disease (CKD): earlier diagnosis of CKD stage 3 and higher. This finding was even more significant for seniors in areas of higher deprivation, including rural America, where CKD disproportionately impacts seniors.3
- Medication Adherence: Non-adherence to medications for diabetes, high blood pressure, and high cholesterol is common and associated with worse chronic disease control, increased disease-related complications, and higher healthcare costs. Counterpart Assistant alerting PCPs to patients’ medication non-adherence led to increased medication fills on the day of the Counterpart Assistant visit, with adherence remaining higher 90 days after the visit.4
Outcomes like these, from earlier diagnosis and management of chronic conditions to better medication adherence, contributed to Clover Health PPO plans’ 4 Star rating for 2025, including achieving 4.94 out of 5 Stars on HEDIS measures, the top-performing score on core HEDIS measures for Medicare Advantage plans with over 2,000 members nationwide.5
Looking ahead
Clover Health looks forward to working with CMS, industry networks, and technology partners to expand data-sharing pathways, providing every doctor, and the patients they care for, the same digital access and care coordination as the largest health systems.
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and aim to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence and Congestive Heart Failure, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
About Counterpart Health
Counterpart Health, a subsidiary of Clover Health Investments, Corp., or Clover Health, is a leading AI powered physician enablement platform. Counterpart Health’s flagship software platform, Counterpart Assistant, was incubated by Clover Health as Clover Assistant and has helped improve plan performance and clinical outcomes for Medicare members through proprietary AI technology. Counterpart Health extends the benefits of the data-driven technology platform outside of Clover Health’s Medicare Advantage plan to a wider audience, to enable enhanced patient outcomes and reduced healthcare costs nationwide. Clover Health has published data demonstrating the technology’s impact on Medication Adherence and Congestive Heart Failure, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Visit: www.cloverhealth.com
Investor Relations:
Ryan Schmidt
investors@cloverhealth.com
Press Inquiries:
press@cloverhealth.com
1 See here for more details.
2 See here for more details.
3 See here for more details.
4 See here for more details.
5 4.94 is the weighted average of the measure scores in the CMS Star Ratings for which the primary data source was HEDIS and for which Clover was eligible to be rated. The calculation uses the same weighting used by CMS for the measures in calculating the overall Star score. The analysis targets non-SNP (Special Needs Plan) HEDIS measures for plans with more than 2,000 contracted lives. Exclusions include measures like C06 (Medication Review) and C07 (Pain Assessment), which are only relevant to SNP plans. Not all contracts offer SNPs, therefore those measures were excluded to enhance the accuracy of comparison across contracts. For detailed methodology and the HEDIS performance of the broader industry visit, please see here.
FAQ
What clinical outcomes has Clover Health's Counterpart Assistant achieved?
What is Clover Health's Medicare Star Rating for 2025?
How does Clover Health's Counterpart Assistant platform work?
How does Clover Health support rural healthcare providers?
What is CLOV's role in the White House and CMS healthcare data initiative?
